1)Amengual O, Atsumi T:Antiphospholipid syndrome, “the best prophet of the future”. Mod Rheumatol 28:409-416, 2018 PMID 29385876
2)Miyakis S, et al:International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome(APS). J Thromb Haemost 4:295-306, 2006 PMID 16420554
3)Barbhaiya M, et al;ACR/EULAR APS Classification Criteria Collaborators:2023 ACR/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis 82:1258-1270, 2023 PMID 37640450
4)Barbhaiya M, et al;ACR/EULAR APS Classification Criteria Collaborators:The 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Arthritis Rheumatol 75:1687-1702, 2023 PMID 37635643
5)Ogata Y, et al:Morbidity and mortality in antiphospholipid syndrome based on cluster analysis;A 10-year longitudinal cohort study. Rheumatology(Oxford)60:1331-1337, 2021 PMID 32944779
6)Tektonidou MG, et al:EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 78:1296-1304, 2019 PMID 31092409